Skip to main content

Olympus Corporation (7733.T)

Japan Exchange Group Healthcare Medical - Instruments & SuppliesView data quality →
53.5Fair

ValueMarkers Composite Index

Top 48%#23,040 of 44,707
Undervalued

84% below intrinsic value ($65)

UndervaluedFair ValueOvervalued
Piotroski
7/9
Strong
Beneish
-2.99
Low Risk
Altman
3.27
Safe
DCF Value
$65
Undervalued
ROIC
9.5%
Adequate
P/E
20.6
Fair
Updated: ·Source: Data sourced from SEC filings and institutional providers. Not financial advice.·Report data issue

Olympus Corporation (7733.T) — VMCI valuation read

7733.T prints VMCI 54/100 inside the Healthcare sector, where the median sits at 50. The 4-point above-median delta is the cleanest single-number summary of Olympus Corporation's composite stance, and in the mid-cap bucket it places the share ahead of the typical peer on the five-pillar mix.

On 7733.T, the SEC EDGAR Form 4 stream shows no insider buys or sells in the past 30 days. Quiet tapes happen; they just remove a signal that bull and bear cases sometimes lean on for confirmation.

**Investor frame.** 7733.T trades at 22.0x earnings, 22% above the Healthcare median of 18.0x; that is the value line. ROIC of 10.0% sits 0.0pp above the Healthcare median (10.0%); that is the quality line. net debt to EBITDA of -1.6x leaves covenant headroom; that is the risk line for Olympus Corporation on the trailing financials.

7733.T fell 3.3% over the trailing 7 days, with a +4.9% read on a 30-day basis.

Olympus Corporation manufactures and sells precision machineries and instruments worldwide. It operates through four segments: Endoscopic Solutions Business, Therapeutic Solutions Business, Scientific Solutions Business, and Others. The Endoscopic Solutions Business segment offers gastrointestinal and surgical endoscopes, endoscopy system, and repair services. The Therapeutic Solutions Business segment provides urology, gynecology, ear, nose, and throat products; endo-therapy and energy devices; and surgical single-use devices. The Scientific Solutions Business segment offers biological and industrial microscopes, industrial endoscopes and videoscopes, non-destructive testing equipment, and X-ray fluorescence (XRF) analyzers. The Others segment offers biomedical materials and orthopedic equipment. The company also offers medical devices, such as surgical microscopes, endoscope reprocessors, electrosurgical devices, and respiratory-endotherapy devices, as well as system integration and maintenance/services. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003. Olympus Corporation was founded in 1919 and is headquartered in Tokyo, Japan.

CEO: Robert John White28,838 employeesJPwww.olympus-global.com

Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.

Browse More

Key metrics explained

Definitions, formulas, and how ValueMarkers calculates each indicator used in 7733.T’s VM Score.

Explore More

Compare Competitors

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.